Cargando…

FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer

PURPOSE: To validate whether FAM70B, which was found in our micro-array profiling as a prognostic marker for cancer survival, could accurately predict prognosis in patients with muscle-invasive bladder cancer (MIBC). MATERIALS AND METHODS: A total of 124 patients with MIBC were enrolled in this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Ho-Won, Yoon, Hyung-Yoon, Ha, Yun-Sok, Kim, Won Tae, Kim, Yong-June, Yun, Seok-Joong, Lee, Sang-Cheol, Kim, Wun-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460001/ https://www.ncbi.nlm.nih.gov/pubmed/23060996 http://dx.doi.org/10.4111/kju.2012.53.9.598

Ejemplares similares

mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer
por: Yoon, Hyung-Yoon, et al.
Publicado: (2013)

Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis
por: Jeong, Pildu, et al.
Publicado: (2015)

Granular Cell Tumor of the Urinary Bladder
por: Kang, Ho-Won, et al.
Publicado: (2010)

Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2
por: Kim, Ye-Hwan, et al.
Publicado: (2014)

Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer
por: Kim, Young-Won, et al.
Publicado: (2015)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2011)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
por: Kim, Tae-Hwan, et al.
Publicado: (2009)

Identification of C16orf74 as a Marker of Progression in Primary Non-Muscle Invasive Bladder Cancer
por: Kim, Won Tae, et al.
Publicado: (2010)

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer
por: Lee, Il-Seok, et al.
Publicado: (2017)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
por: Kim, Won Tae, et al.
Publicado: (2018)

DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis
por: Yoon, Hyung-Yoon, et al.
Publicado: (2012)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Chronological Trends in Clinical and Urinary Metabolic Features over 20 Years in Korean Urolithiasis Patients
por: Kang, Ho Won, et al.
Publicado: (2017)

Impact of Transobturator Tape Treatment on Overactive Bladder Symptoms, Particularly Nocturia, in Patients With Mixed Urinary Incontinence
por: Lee, Sang Keun, et al.
Publicado: (2014)

Nutritional status assessed by the Controlling Nutritional Status (CONUT) score as a predictor of recurrence of urolithiasis
por: Lee, Hee Youn, et al.
Publicado: (2021)

Lower Levels of Human MOB3B Are Associated with Prostate Cancer Susceptibility and Aggressive Clinicopathological Characteristics
por: Kim, Eun-Ah, et al.
Publicado: (2015)

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
por: Kim, Wun-Jae, et al.
Publicado: (2010)

Docetaxel-Induced Fatal Interstitial Pneumonitis in a Patient with Castration-Resistant Prostate Cancer
por: Min, Byung-Dal, et al.
Publicado: (2012)

Expectant Management of Ureter Stones: Outcome and Clinical Factors of Spontaneous Passage in a Single Institution's Experience
por: Tchey, Dong-Un, et al.
Publicado: (2011)

Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer
por: Shim, Ui Jae, et al.
Publicado: (2013)

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria
por: Kim, Won Tae, et al.
Publicado: (2016)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

Comparison of Metabolic Risk Factors in Urolithiasis Patients according to Family History
por: Park, Cheol, et al.
Publicado: (2010)

Phosphaturia as a Promising Predictor of Recurrent Stone Formation in Patients with Urolithiasis
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2010)

A high basal metabolic rate is an independent predictor of stone recurrence in obese patients
por: Kang, Ho Won, et al.
Publicado: (2021)

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer
por: Kim, Ye-Hwan, et al.
Publicado: (2016)

For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
por: Kim, Won Tae, et al.
Publicado: (2019)

The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease
por: Kim, Young-Won, et al.
Publicado: (2015)

Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways
por: Lee, Eun Hye, et al.
Publicado: (2022)

Usefulness of a Combined Approach of T1-Weighted, T2-Weighted, Dynamic Contrast-Enhanced, and Diffusion-Weighted Imaging in Prostate Cancer
por: Min, Byung Dal, et al.
Publicado: (2012)

Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall
por: Ha, Yun-Sok, et al.
Publicado: (2010)

How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
por: Yun, Seok Joong, et al.
Publicado: (2016)

Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
por: Kim, Yong-June, et al.
Publicado: (2016)

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
por: Piao, Xuan-Mei, et al.
Publicado: (2022)

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
por: Jin, Xing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_87mc76ck6jgplqk2bua0gkvuca